A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.
Video content above is prompted by the following:
Could you briefly provide an overview of the new treatments available for retinal vascular diseases?
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.